Frankfurt - Delayed Quote EUR
Medical Facilities Corporation (31F.F)
9.20
+0.10
+(1.10%)
As of 8:02:00 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
331,529
331,529
339,576
424,551
398,633
Cost of Revenue
111,646
111,646
120,365
143,925
130,027
Gross Profit
219,883
219,883
219,211
280,626
268,606
Operating Expense
155,979
155,979
170,035
229,138
191,248
Operating Income
63,904
63,904
49,176
51,488
77,358
Net Non Operating Interest Income Expense
-10,471
-10,471
-15,613
-4,869
-26,310
Other Income Expense
-2,324
-2,324
1,347
-29,116
-159
Pretax Income
51,109
51,109
34,910
17,503
50,889
Tax Provision
-5,685
-5,685
6,064
5,208
4,396
Net Income Common Stockholders
73,490
73,490
18,503
-4,405
15,500
Diluted NI Available to Com Stockholders
73,490
73,490
18,503
-4,405
15,500
Basic EPS
3.06
3.06
0.73
-0.15
0.50
Diluted EPS
3.06
3.06
0.73
-0.15
0.50
Basic Average Shares
24,000.88
24,000.88
25,254.83
29,366.99
31,092.89
Diluted Average Shares
24,000.88
24,000.88
25,254.83
29,366.99
31,126.78
Total Operating Income as Reported
61,639
61,639
49,176
34,939
77,358
Total Expenses
267,625
267,625
290,400
373,063
321,275
Net Income from Continuing & Discontinued Operation
73,490
73,490
18,503
-4,405
15,500
Normalized Income
26,697.40
26,697.40
1,972.56
15,644.36
15,531.06
Interest Income
1,867
1,867
717
8,543
76
Interest Expense
12,094
12,094
15,984
12,886
25,740
Net Interest Income
-10,471
-10,471
-15,613
-4,869
-26,310
EBIT
63,203
63,203
50,894
30,389
76,629
EBITDA
82,572
82,572
72,431
51,152
103,398
Reconciled Cost of Revenue
109,095
109,095
117,133
143,925
130,027
Reconciled Depreciation
19,369
19,369
21,537
20,763
26,769
Net Income from Continuing Operation Net Minority Interest
24,722
24,722
3,350
-4,405
15,500
Total Unusual Items Excluding Goodwill
-2,324
-2,324
1,667
-28,542
-34
Total Unusual Items
-2,324
-2,324
1,667
-28,542
-34
Normalized EBITDA
84,896
84,896
70,764
79,694
103,432
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-348.60
-348.60
289.56
-8,492.64
-2.94
12/31/2021 - 4/21/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade